As technology has altered the way we communicate with each other, it is no secret that the written word has lost leverage in the eyes of content consumers. That is why video content, specifically live video, has superseded blog and written content in driving...
Activation of the PI3K-Akt-mTOR signaling pathway is common in advanced castration resistant prostate cancer (CRPC), typically through PTEN loss. Preclinical studies suggest that Akt-driven CaP cells are genetically susceptible to mammalian target of rapamycin (mTOR,...
– Phase 1b dose escalation clinical trial confirmed safety, preliminary efficacy and identified the recommended phase 2 dose of onvansertib – Complete response (CR + CRi) achieved in 5 of 21 patients treated with onvansertib in combination with decitabine...
Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), today announced that the first patient has been enrolled in its Phase 2 clinical trial to evaluate the efficacy and safety of its topical combination foam, comprised of minocycline 3% and adapalene 0.3%, FCD105 for the...
Data to be presented at the 2019 International Congress of Parkinson’s Disease and Movement Disorders Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, will present new data from a Phase 2 clinical trial...
Email
Text